Immunotherapy may hold the key to defeating virally associated cancersNovember 25, 2018Head & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastroenterologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Meeting the potential of immunotherapy: new targets provide rational combinationsAugust 15, 2018GastroenterologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersImmunotherapyLymphoma & Plasma Cell DisordersMelanoma
Recurrence of a small gastric gastrointestinal stromal tumor with high mitotic indexJune 21, 2018GastroenterologyPatient & Survivor Care
Bevacizumab-awwb becomes first biosimilar approved for cancer treatmentApril 29, 2018Gynecologic CancerGastroenterologyLung Cancer
Massive liver metastasis from colon adenocarcinoma causing cardiac tamponadeFebruary 18, 2018GastroenterologyPatient & Survivor Care
Expanding treatment options for diverse neuroendocrine tumorsDecember 15, 2017GastroenterologyLung Cancer
Pembrolizumab for dMMR/MSI-H tumors marks first tumor agnostic FDA approvalDecember 15, 2017GastroenterologyGynecologic Cancer
Hallmark tumor metabolism becomes a validated therapeutic targetDecember 10, 2017Breast CancerGastroenterologyGenitourinary CancerLeukemia, Myelodysplasia, Transplantation
Biosimilars poised to save $54 billion over the next decadeOctober 25, 2017Business of MedicineGastroenterology
An ASCO 2017 recap: significant advances continueSeptember 8, 2017Breast CancerGenitourinary CancerGastroenterologyPatient & Survivor CareImmunotherapy
Management of high-grade pleomorphic sarcoma with colon metastasisSeptember 7, 2017Sarcoma & GISTPatient & Survivor CareGastroenterology
